LobbyingAdvocate Health lobbying by quarter
Advocate Health's latest lobbying report covers Q2 2026, at $450K. The four quarters Q4 2025–Q3 2026 total $2M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Advocate Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $650K | 1 |
| Q1 2023 | $420K | 1 |
| Q2 2023 | $320K | 1 |
| Q3 2023 | $280K | 1 |
| Q4 2023 | $290K | 1 |
| Q1 2024 | $510K | 1 |
| Q2 2024 | $550K | 1 |
| Q3 2024 | $320K | 1 |
| Q4 2024 | $360K | 1 |
| Q1 2025 | $850K | 1 |
| Q2 2025 | $380K | 1 |
| Q3 2025 | $390K | 1 |
| Q4 2025 | $400K | 1 |
| Q1 2026 | $1.2M | 1 |
| Q2 2026 | $450K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3.7M · 15 reports
- Medicare and Medicaid$3.7M · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health Resources & Services Administration (HRSA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAdvocate Health | $7.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MEAGAN THOMPSON | Sr Policy Advisor, Fellow: Rep. Robin Kelly; Sr Leg. Asst., Leg. Asst.: Rep. Sean Casten | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | In-house | $450K |
| 04/24for Q1 | In-house | $1.2M |
| 04/20for Q1 | In-house | $1.2M |
| 01/20for Q4 2025 | In-house | $400K |
| 25/10/15for Q3 2025 | In-house | $390K |
| 25/07/21for Q2 2025 | In-house | $380K |
| 25/04/17for Q1 2025 | In-house | $850K |
| 25/01/17for Q4 2024 | In-house | $360K |
| 24/10/21for Q3 2024 | In-house | $320K |
| 24/07/17for Q2 2024 | In-house | $550K |
| 24/04/16for Q1 2024 | In-house | $510K |
| 24/01/19for Q4 2023 | In-house | $290K |
| 23/10/20for Q3 2023 | In-house | $280K |
| 23/07/19for Q2 2023 | In-house | $320K |
| 23/04/20for Q1 2023 | In-house | $420K |
| 23/01/19for Q4 2022 | In-house | $650K |